<DOC>
	<DOC>NCT01241110</DOC>
	<brief_summary>Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin +Metronidazole in outpatients with Pelvic Inflammatory Disease. Materials and Methods: Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy</brief_summary>
	<brief_title>To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment</brief_title>
	<detailed_description>Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy</detailed_description>
	<mesh_term>Pelvic Inflammatory Disease</mesh_term>
	<mesh_term>Pelvic Infection</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<criteria>Eligibility criteria were having three out of five following symptoms: alower abdominal pain, bvaginal discharges, c adnexal tenderness, dcervical motion tenderness (CMT), ecervisitis. Excluding criteria were as follows: aunmarried women, bpregnant women, cwomen with infection during menstruation, d history of abortion or miscarriage during the last month, eunderlying diseases such as diabetes, fused antibiotics in the last month, or allergy to the antibiotics used in the study, ghistory of Pelvic Inflammatory Disease within the last year, and h suspicion of being multi partner.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>PID, Ofloxacin, Azitromicine, Metronidazole</keyword>
</DOC>